News & Insights
Stay Informed With Our Latest Updates
Explore our comprehensive collection of news and in-depth insights spanning practice areas, industries, and regions.
Firm News January 14, 2026
Gibson Dunn Advises Immedica Pharma on Acquisition of Neurocrine Group
Gibson Dunn is advising Immedica Pharma AB on the acquisition of Neurocrine Group Limited.
Firm News March 6, 2025
Gibson Dunn Advised Eurazeo on Planned Investment in Mapal
Gibson Dunn advised investment manager Eurazeo in connection with its planned investment in software provider Mapal and the acquisition of …
Firm News March 6, 2025
Gibson Dunn Advised Oaktree Capital Management and Co-Shareholders on Sale of Controlling Stake in OSM Thome
Gibson Dunn advised funds managed by Oaktree Capital Management, L.P. and its co-shareholders, Skagerak and OSM Maritime Partners, in connection …
Firm News October 24, 2024
Gibson Dunn Advises Funds Managed by Oaktree in the Acquisition of LED Group
Gibson Dunn advised funds managed by the Power Opportunities strategy of Oaktree Capital Management, L.P. (“Oaktree”), a leading global investment manager specialising in alternative investments, on its partnership with LED Enterprises Limited (“LED Group” and the “Group”), operating through the ROBUS and FuseBox brands, to develop a premier platform for building electrification products and energy transition solutions.
Firm News October 24, 2024
Gibson Dunn Advises Cold Chain Technologies on Acquisition of Tower Cold Chain
Gibson Dunn advised Cold Chain Technologies, a portfolio company of long-standing client Aurora Capital Partners, on its acquisition of Tower Cold Chain, a global leader in passive reusable cold chain solutions for the pharmaceutical and life sciences industries.